GYENNO SCIENCE

GYENNO SCIENCE GYENNO Science Focus on Diseases of the Central Nervous System. Our Vision is Advance Neurology with Emerging Technologies for Great Patient Benefits.

GYENNO Science, a team of professionals from world top 500 companies with great experiences, is founded in Shenzhen, China, 2013. We are Focus on Diseases of the Central Nervous System.

Parkinson's disease is a common neurodegenerative disorder among the elderly. Currently, there are about 10 million peop...
08/05/2024

Parkinson's disease is a common neurodegenerative disorder among the elderly. Currently, there are about 10 million people worldwide suffering from Parkinson's disease.
However, it is difficult for us to notice the presence of Parkinson's patients in our daily lives. The uncontrollable symptoms cause them significant physical discomfort and psychological burden.
GYENNO SCIENCE has planned and filmed a series of public welfare documentaries titled "Recreated Dopamine" hoping to raise public awareness, understanding, and support for this group.
This is the first installment of the series, "Belief in Tomorrow" which tells the story of a young patient diagnosed with Parkinson's disease at the age of 19, depicting nearly 20 years of his life and inner journey. The incessant tremors and involuntary movements have been like a heavy shackle that has confined his heart for years, intensifying the young man's sense of shame about his illness.
Yet, after 20 years, he has gradually gained the courage to face everything with equanimity.

Parkinson's disease is a common neurodegenerative disorder among the elderly. Currently, there are about 10 million people worldwide suffering from Parkinson...

In this study, the quantitative assessment of non-motor symptoms of Parkinson's disease (hallucinations) was realized th...
22/03/2024

In this study, the quantitative assessment of non-motor symptoms of Parkinson's disease (hallucinations) was realized through VR.
Matrix Pro developed by GYENNO Science utilized machine vision and multiple fusion perceptual technologies in combination with artificial intelligence algorithms to intelligently quantify motor symptoms on the MDS-UPDRS III classic scale.

Virtual reality, robotics and digital online technologies reveal heightened visual overestimation when estimating the number of humans, indexing presence hallucinations in healthy participants and patients with Parkinson’s disease.

Innovative therapies continue to emerge, which is exciting. But Parkinson's disease is still subject to under-diagnosis ...
14/03/2024

Innovative therapies continue to emerge, which is exciting. But Parkinson's disease is still subject to under-diagnosis and misdiagnosis in many countries. That's what we're doing, and GYENNO is developing a range of innovative technologies to enable intelligent quantitative assessment of Parkinson's disease. This enables a complete pathway from assessment to diagnosis to treatment.😃

A novel therapy designed to clear toxic clumps of a protein thought to be responsible for Parkinson's disease has shown promise in early clinical trials.

An incredible milestone and just the beginning of a very exciting future!👏
22/08/2023

An incredible milestone and just the beginning of a very exciting future!👏

A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation. This is the first ...

AI technology has the potential to transform early detection and assessment of many diseases.
22/08/2023

AI technology has the potential to transform early detection and assessment of many diseases.

The study detected physical differences in the eyes of people with Parkinson's and those without the condition.

Cool! GYENNO is also using AI technology to solve the problem of not being able to quantitatively assess Parkinson's dis...
17/08/2023

Cool! GYENNO is also using AI technology to solve the problem of not being able to quantitatively assess Parkinson's disease! We hope to help more patients out of their predicament in the future.

LONDON— Personalized treatments for Parkinson's disease may soon be a reality. Scientists have used artificial intelligence (AI) to identify different

I think if it has something to do with the intense collision? Boxing is the same way.
17/08/2023

I think if it has something to do with the intense collision? Boxing is the same way.

Researchers identified a potential link between playing tackle football and an increased risk of Parkinson’s disease (PD).

It's important to adjust a positive mindset as much as possible to slow the progression of Parkinson's disease through t...
09/08/2023

It's important to adjust a positive mindset as much as possible to slow the progression of Parkinson's disease through training and maintaining good communication with your doctor about your treatment!

In the fall of 2018, the pianist Nicolas Hodges noticed his body shaking. He brought it up at a routine doctor’s appointment in Tübingen, Germany, where he

More than 60% of Parkinson's disease patients are diagnosed with high blood pressure.Scientists from China analysed two ...
09/08/2023

More than 60% of Parkinson's disease patients are diagnosed with high blood pressure.
Scientists from China analysed two years of clinical results using data from the Parkinson's Disease Progression Marker Initiative (PDPMI).

More than 60% of Parkinson's disease patients are diagnosed with high blood pressure, leading researchers to explore a possible connection.

Follow Daily Parkinson's Cutting Edge News
04/08/2023

Follow Daily Parkinson's Cutting Edge News

Yulan Xiong and her team have made a novel discovery about how a gene responsible for Parkinson's Disease in many cases can be regulated. Yulan

Connecticut researchers uncover regulator compound with potential to treat Parkinson's disease
04/08/2023

Connecticut researchers uncover regulator compound with potential to treat Parkinson's disease

An assistant professor at UConn Health and a team of researchers have reportedly discovered a regulator compound which hold the potential to treat Parkinson's disease.

Beyond Reward, Dopamine Drives Movement
04/08/2023

Beyond Reward, Dopamine Drives Movement

Researchers discovered a genetic subtype of dopamine neurons that fires during movement, contrary to the long-standing belief that dopamine neurons primarily respond to rewards.

Address

8F, Building B2, Creative City, Chuang Ke Road, Xili Street, Nanshan District
Shenzhen
518057

Telephone

+8675586724035

Website

Alerts

Be the first to know and let us send you an email when GYENNO SCIENCE posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to GYENNO SCIENCE:

Shortcuts

Share

Category